LRRK2 and colitis: Although further confirmation is needed, we propose that these cellular phenotypes likely contribute to the increased severity of colitis observed in LRRK2-N2081D mutation carriers by enhancing immune cell infiltration and sustaining inflammatory responses in intestinal tissue.